Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Updated overview on von Willebrand disease: focus on the interest of genotyping.

Itzhar-Baikian N, Boisseau P, Joly B, Veyradier A.

Expert Rev Hematol. 2019 Oct 6:1-14. doi: 10.1080/17474086.2019.1670638. [Epub ahead of print]

PMID:
31536379
2.

Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.

Béranger N, Benghezal S, Savigny S, Capdenat S, Joly BS, Coppo P, Stepanian A, Veyradier A.

Thromb Res. 2019 Sep;181:29-35. doi: 10.1016/j.thromres.2019.07.012. Epub 2019 Jul 16.

PMID:
31330376
3.

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients.

Nicolini FE, Dulucq S, Boureau L, Cony-Makhoul P, Charbonnier A, Escoffre-Barbe M, Rigal-Huguet F, Coiteux V, Varet B, Dubruille V, Lenain P, Rousselot P, Rea D, Guerci-Bresler A, Legros L, Liu J, Gardembas M, Ianotto JC, Turlure P, Johnson-Ansah H, Martiniuc J, Jardel H, Joly B, Zunic P, Henni T, Villemagne B, Berger MG, Cayssials E, Guilhot F, Larosa F, Guilhot J, Etienne G, Mahon FX.

Clin Cancer Res. 2019 Jul 10. doi: 10.1158/1078-0432.CCR-18-3373. [Epub ahead of print]

PMID:
31292142
4.

An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura.

Joly BS, Coppo P, Veyradier A.

Expert Rev Hematol. 2019 Jun;12(6):383-395. doi: 10.1080/17474086.2019.1611423. Epub 2019 May 20.

PMID:
31107120
5.

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Pertesi M, Vallée M, Wei X, Revuelta MV, Galia P, Demangel D, Oliver J, Foll M, Chen S, Perrial E, Garderet L, Corre J, Leleu X, Boyle EM, Decaux O, Rodon P, Kolb B, Slama B, Mineur P, Voog E, Le Bris C, Fontan J, Maigre M, Beaumont M, Azais I, Sobol H, Vignon M, Royer B, Perrot A, Fuzibet JG, Dorvaux V, Anglaret B, Cony-Makhoul P, Berthou C, Desquesnes F, Pegourie B, Leyvraz S, Mosser L, Frenkiel N, Augeul-Meunier K, Leduc I, Leyronnas C, Voillat L, Casassus P, Mathiot C, Cheron N, Paubelle E, Moreau P, Bignon YJ, Joly B, Bourquard P, Caillot D, Naman H, Rigaudeau S, Marit G, Macro M, Lambrecht I, Cliquennois M, Vincent L, Helias P, Avet-Loiseau H, Moreno V, Reis RM, Varkonyi J, Kruszewski M, Vangsted AJ, Jurczyszyn A, Zaucha JM, Sainz J, Krawczyk-Kulis M, Wątek M, Pelosini M, Iskierka-Jażdżewska E, Grząśko N, Martinez-Lopez J, Jerez A, Campa D, Buda G, Lesueur F, Dudziński M, García-Sanz R, Nagler A, Rymko M, Jamroziak K, Butrym A, Canzian F, Obazee O, Nilsson B, Klein RJ, Lipkin SM, McKay JD, Dumontet C.

Leukemia. 2019 Sep;33(9):2324-2330. doi: 10.1038/s41375-019-0452-6. Epub 2019 Apr 9. No abstract available.

6.

Inherited Thrombotic Thrombocytopenic Purpura Revealed by Recurrent Strokes in a Male Adult: Case Report and Literature Review.

Beauvais D, Venditti L, Chassin O, Joly B, Ameri A, Boisseau P, Lambotte O, Coppo P, Veyradier A, Denier C.

J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1537-1539. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.011. Epub 2019 Mar 28. Review.

PMID:
30930238
7.

Transfer of ADAMTS13 antibody-mediated thrombotic thrombocytopenic purpura via kidney transplantation.

Zafrani L, Dekimpe C, Joly BS, Roose E, Fieux F, Azoulay E, Peraldi MN, Durrbach A, Coppo P, Vanhoorelbeke K, Veyradier A.

Haematologica. 2019 Jun;104(6):e277-e280. doi: 10.3324/haematol.2019.219063. Epub 2019 Feb 28. No abstract available.

8.

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.

Casasnovas RO, Bouabdallah R, Brice P, Lazarovici J, Ghesquieres H, Stamatoullas A, Dupuis J, Gac AC, Gastinne T, Joly B, Bouabdallah K, Nicolas-Virelizier E, Feugier P, Morschhauser F, Delarue R, Farhat H, Quittet P, Berriolo-Riedinger A, Tempescul A, Edeline V, Maisonneuve H, Fornecker LM, Lamy T, Delmer A, Dartigues P, Martin L, André M, Mounier N, Traverse-Glehen A, Meignan M.

Lancet Oncol. 2019 Feb;20(2):202-215. doi: 10.1016/S1470-2045(18)30784-8. Epub 2019 Jan 15.

PMID:
30658935
9.

Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients.

Schelpe AS, Roose E, Joly BS, Pareyn I, Mancini I, Biganzoli M, Deckmyn H, Voorberg J, Fijnheer R, Peyvandi F, De Meyer SF, Coppo P, Veyradier A, Vanhoorelbeke K.

Haematologica. 2019 Jun;104(6):1268-1276. doi: 10.3324/haematol.2018.205666. Epub 2018 Dec 6.

10.

ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman Syndrome.

Joly BS, Boisseau P, Roose E, Stepanian A, Biebuyck N, Hogan J, Provot F, Delmas Y, Garrec C, Vanhoorelbeke K, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

Thromb Haemost. 2018 Nov;118(11):1902-1917. doi: 10.1055/s-0038-1673686. Epub 2018 Oct 12.

PMID:
30312976
11.

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.

Gressin R, Daguindau N, Tempescul A, Moreau A, Carras S, Tchernonog E, Schmitt A, Houot R, Dartigeas C, Pignon JM, Corm S, Banos A, Mounier C, Dupuis J, Macro M, Fleury J, Jardin F, Sarkozy C, Damaj G, Feugier P, Fornecker LM, Chabrot C, Dorvaux V, Bouadallah K, Amorin S, Garidi R, Voillat L, Joly B, Celigny PS, Morineau N, Moles MP, Zerazhi H, Fontan J, Arkam Y, Alexis M, Delwail V, Vilque JP, Ysebaert L, Le Gouill S, Callanan MB; Lymphoma Study Association.

Haematologica. 2019 Jan;104(1):138-146. doi: 10.3324/haematol.2018.191429. Epub 2018 Aug 31.

12.

Pediatric thrombotic thrombocytopenic purpura.

Joly BS, Coppo P, Veyradier A.

Eur J Haematol. 2018 Oct;101(4):425-434. doi: 10.1111/ejh.13107. Epub 2018 Aug 22. Review.

PMID:
29889319
13.

The clinical features of cardiac involvement in patients with severe thrombotic thrombocytopenic purpura.

Fourmont AM, Zafrani L, Mariotte E, Galicier L, Joly B, Merceron S, Bertinchamp R, Lemiale V, de Jong A, Valade S, Darmon M, Veyradier A, Azoulay E.

Intensive Care Med. 2018 Jun;44(6):963-965. doi: 10.1007/s00134-018-5216-7. Epub 2018 May 11. No abstract available.

PMID:
29752524
14.

Deep venous thrombosis treated by rivaroxaban in a young patient with type Ia carbohydrate-deficient glycoprotein (CDG) syndrome.

Lefrère B, Stepanian A, Itzhar-Baïkian N, Charles P, Hadj-Ali A, Joly B, Alhenc-Gelas M, Drouet L, Veyradier A, Siguret V.

Ann Biol Clin (Paris). 2018 Apr 1;76(2):217-223. doi: 10.1684/abc.2018.1324.

PMID:
29623892
15.

A Review of Public Health Training Needs Assessment Approaches: Opportunities to Move Forward.

Joly BM, Coronado F, Bickford BC, Leider JP, Alford A, McKeever J, Harper E.

J Public Health Manag Pract. 2018 Nov/Dec;24(6):571-577. doi: 10.1097/PHH.0000000000000774.

PMID:
29521851
16.

Understanding thrombotic microangiopathies in children.

Joly BS, Zheng XL, Veyradier A.

Intensive Care Med. 2018 Sep;44(9):1536-1538. doi: 10.1007/s00134-018-5059-2. Epub 2018 Jan 24. No abstract available.

17.

Are Screening Tests Reliable to Rule Out Direct Oral Anticoagulant Plasma Levels at Various Thresholds (30, 50, or 100 ng/mL) in Emergency Situations?

Jabet A, Stepanian A, Golmard JL, Flaujac C, Joly BS, Gouin-Thibault I, Siguret V.

Chest. 2018 Jan;153(1):288-290. doi: 10.1016/j.chest.2017.09.047. No abstract available.

PMID:
29307427
18.

An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura.

Roose E, Schelpe AS, Joly BS, Peetermans M, Verhamme P, Voorberg J, Greinacher A, Deckmyn H, De Meyer SF, Coppo P, Veyradier A, Vanhoorelbeke K.

J Thromb Haemost. 2018 Feb;16(2):378-388. doi: 10.1111/jth.13922. Epub 2018 Jan 23.

PMID:
29222940
19.

Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.

Bridoux F, Carron PL, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A, Joly B, Peraldi MN, Arnulf B, Vigneau C, Lamy T, Wynckel A, Kolb B, Royer B, Rabot N, Benboubker L, Combe C, Jaccard A, Moulin B, Knebelmann B, Chevret S, Fermand JP; MYRE Study Group.

JAMA. 2017 Dec 5;318(21):2099-2110. doi: 10.1001/jama.2017.17924.

20.

Thrombin generation test as a marker for high risk venous thrombosis pregnancies.

Joly BS, Sudrié-Arnaud B, Barbay V, Borg JY, Le Cam Duchez V.

J Thromb Thrombolysis. 2018 Jan;45(1):114-121. doi: 10.1007/s11239-017-1572-3.

PMID:
29032523
21.

Success rates in smoking cessation: Psychological preparation plays a critical role and interacts with other factors such as psychoactive substances.

Joly B, Perriot J, d'Athis P, Chazard E, Brousse G, Quantin C.

PLoS One. 2017 Oct 11;12(10):e0184800. doi: 10.1371/journal.pone.0184800. eCollection 2017.

22.

Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice.

Tersteeg C, Joly BS, Gils A, Lijnen R, Deckmyn H, Declerck PJ, Plaimauer B, Coppo P, Veyradier A, Maas C, De Meyer SF, Vanhoorelbeke K.

J Thromb Haemost. 2017 Dec;15(12):2432-2442. doi: 10.1111/jth.13859. Epub 2017 Oct 27.

PMID:
28981198
23.

Thrombotic thrombocytopenic purpura.

Joly BS, Coppo P, Veyradier A.

Blood. 2017 May 25;129(21):2836-2846. doi: 10.1182/blood-2016-10-709857. Epub 2017 Apr 17. Review.

PMID:
28416507
24.

Understanding therapeutic targets in thrombotic thrombocytopenic purpura.

Joly BS, Vanhoorelbeke K, Veyradier A.

Intensive Care Med. 2017 Sep;43(9):1398-1400. doi: 10.1007/s00134-016-4662-3. Epub 2017 Jan 23. No abstract available.

PMID:
28116452
25.

Smoking cessation attempts: is it useful to treat hard core smokers?

Joly B, D'Athis P, Gerbaud L, Hazart J, Perriot J, Quantin C.

Tob Induc Dis. 2016 Nov 3;14:34. eCollection 2016.

26.

Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.

Joly BS, Stepanian A, Leblanc T, Hajage D, Chambost H, Harambat J, Fouyssac F, Guigonis V, Leverger G, Ulinski T, Kwon T, Loirat C, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

Lancet Haematol. 2016 Nov;3(11):e537-e546. doi: 10.1016/S2352-3026(16)30125-9. Epub 2016 Oct 3.

PMID:
27720178
27.
28.

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.

Reboursiere E, Le Bras F, Herbaux C, Gyan E, Clavert A, Morschhauser F, Malak S, Sibon D, Broussais F, Braun T, Fornecker LM, Garidi R, Tricot S, Houot R, Joly B, Abarah W, Choufi B, Pham AD, Gac AC, Fruchart C, Marin E, Safar V, Parcelier A, Maisonneuve H, Bachy E, Cartron G, Jaccard A, Tournilhac O, Rossi C, Schirmer L, Martignoles JA, Gaulard P, Tilly H, Damaj G; From the Lymphoma Study Association (LYSA) centers.

Oncotarget. 2016 Dec 20;7(51):85573-85583. doi: 10.18632/oncotarget.10764.

29.

Early Detection, Intervention and Prevention of Psychosis Program: Community Outreach and Early Identification at Six U.S. Sites.

Lynch S, McFarlane WR, Joly B, Adelsheim S, Auther A, Cornblatt BA, Migliorati M, Ragland JD, Sale T, Spring E, Calkins R, Carter CS, Jaynes R, Taylor SF, Downing D.

Psychiatr Serv. 2016 May 1;67(5):510-6. doi: 10.1176/appi.ps.201300236. Epub 2016 Jan 14.

PMID:
26766751
30.

Nocardia nova sphenoid sinusitis and infratemporal fossa abscess.

Giordano A, Cohen-Salmon M, Joly B, Maffiolo C.

Eur Ann Otorhinolaryngol Head Neck Dis. 2016 Apr;133(2):125-7. doi: 10.1016/j.anorl.2015.09.004. Epub 2015 Oct 23.

31.

[Mild hemophilia A fortuitously discovered during Henoch-Schönlein purpura].

Joly B, d'Oiron R, Desconclois C, Bendelac L, Rafowicz A, Meyzer C, Labrune P, Veyradier A.

Arch Pediatr. 2015 Nov;22(11):1167-70. doi: 10.1016/j.arcped.2015.07.014. Epub 2015 Sep 26. French.

PMID:
26412326
32.

Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia.

Ruminy P, Marchand V, Buchbinder N, Larson T, Joly B, Penther D, Lemasle E, Lepretre S, Angot E, Mareschal S, Viailly PJ, Dubois S, Clatot F, Viennot M, Bohers E, Rizzo D, Cornic M, Bertrand P, Girod C, Camus V, Etancelin P, Buchonnet G, Schneider P, Picquenot JM, Vannier JP, Bastard C, Tilly H, Jardin F.

Leukemia. 2016 Mar;30(3):757-60. doi: 10.1038/leu.2015.177. Epub 2015 Jul 3. No abstract available.

PMID:
26139430
33.

Modern teaching of military surgery: why and how to prepare the orthopaedic surgeons before deployment? The French experience.

Mathieu L, Joly B, Bonnet S, Bertani A, Rongiéras F, Pons F, Rigal S.

Int Orthop. 2015 Oct;39(10):1887-93. doi: 10.1007/s00264-015-2741-7. Epub 2015 Mar 25.

PMID:
25804207
34.

Involvement of Arg306 mutation in factor V gene in two young men with ischemic stroke.

Joly B, Menard AL, Ozkul-Wermester O, Triquenot-Bagan A, Guegan-Massardier E, Borg JY, Le Cam-Duchez V.

Blood Coagul Fibrinolysis. 2014 Dec;25(8):916-7. doi: 10.1097/MBC.0000000000000165. No abstract available.

PMID:
25360683
35.

Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement.

Joly B, Stepanian A, Hajage D, Thouzeau S, Capdenat S, Coppo P, Veyradier A.

Thromb Res. 2014 Nov;134(5):1074-80. doi: 10.1016/j.thromres.2014.09.006. Epub 2014 Sep 16.

PMID:
25262108
36.
37.

Maine Center for Disease Control and Prevention: accreditation readiness review.

Marone KP, Joly BM, Birkhimer N, Ricker VJ, Riley B.

J Public Health Manag Pract. 2014 Jan-Feb;20(1):76-8. doi: 10.1097/PHH.0b013e3182a45124. No abstract available.

PMID:
24322694
38.

Introduction to case reports: one goal-many journeys.

Joly B, Davis MV.

J Public Health Manag Pract. 2014 Jan-Feb;20(1):64-5. doi: 10.1097/PHH.0b013e3182a958da. No abstract available.

PMID:
24322690
39.

Transforming public health practice through accreditation (a user guide for the special accreditation issue).

Beitsch LM, Corso LC, Davis MV, Joly BM, Kronstadt J, Riley WJ.

J Public Health Manag Pract. 2014 Jan-Feb;20(1):2-3. doi: 10.1097/PHH.0b013e3182a8ea1e. No abstract available.

PMID:
24322676
40.

Creating quality improvement culture in public health agencies.

Davis MV, Mahanna E, Joly B, Zelek M, Riley W, Verma P, Fisher JS.

Am J Public Health. 2014 Jan;104(1):e98-104. doi: 10.2105/AJPH.2013.301413. Epub 2013 Nov 14.

41.

Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.

Joly B, Barbay V, Borg JY, Le Cam-Duchez V.

Thromb Res. 2013 Sep;132(3):386-91. doi: 10.1016/j.thromres.2013.07.022. Epub 2013 Aug 2.

PMID:
23962423
42.

Driving a public health culture of quality: how far down the highway have local health departments traveled?

Beitsch LM, Rider NL, Joly BM, Leep C, Polyak G.

J Public Health Manag Pract. 2013 Nov-Dec;19(6):569-74. doi: 10.1097/PHH.0b013e31828e25cf.

PMID:
23549372
43.

Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: an ANRS CO16 LYMPHOVIR cohort study.

Terrier B, Costagliola D, Prevot S, Chavez H, Missy P, Rince P, Costello R, Escaut L, Gabarre J, Joly B, Letranchant L, Le Gouill S, Morineau-Le Houssine P, Simon A, Canioni D, Hermine O, Cacoub P, Taoufik Y, Raphael M, Besson C.

J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):249-53. doi: 10.1097/QAI.0b013e31828a77f0.

PMID:
23403861
44.

Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.

Damaj G, Gressin R, Bouabdallah K, Cartron G, Choufi B, Gyan E, Banos A, Jaccard A, Park S, Tournilhac O, Schiano-de Collela JM, Voillat L, Joly B, Le Gouill S, Saad A, Cony-Makhoul P, Vilque JP, Sanhes L, Schmidt-Tanguy A, Bubenheim M, Houot R, Diouf M, Marolleau JP, Béné MC, Martin A, Lamy T.

J Clin Oncol. 2013 Jan 1;31(1):104-10. doi: 10.1200/JCO.2012.43.7285. Epub 2012 Oct 29.

PMID:
23109692
45.

Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.

Mangin F, Dilly S, Joly B, Scuvée-Moreau J, Evans J, Setola V, Roth BL, Liégeois JF.

Bioorg Med Chem Lett. 2012 Jul 15;22(14):4550-4. doi: 10.1016/j.bmcl.2012.05.119. Epub 2012 Jun 7.

PMID:
22738628
46.

Interest of simultaneous Chlamydia trachomatis and Neisseria gonorrhoeae screening at the time of preabortion consultation.

Toyer AL, Trignol-Viguier N, Mereghetti L, Joly B, Blin E, Body G, Goudeau A, Lanotte P.

Contraception. 2012 Nov;86(5):572-6. doi: 10.1016/j.contraception.2012.04.012. Epub 2012 May 26.

PMID:
22633246
47.

Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.

Delfau-Larue MH, de Leval L, Joly B, Plonquet A, Challine D, Parrens M, Delmer A, Salles G, Morschhauser F, Delarue R, Brice P, Bouabdallah R, Casasnovas O, Tilly H, Gaulard P, Haioun C.

Haematologica. 2012 Oct;97(10):1594-602. doi: 10.3324/haematol.2011.061507. Epub 2012 Feb 27.

48.

Measuring quality improvement in public health: the development and psychometric testing of a QI Maturity Tool.

Joly BM, Booth M, Mittal P, Shaler G.

Eval Health Prof. 2012 Jun;35(2):119-47. doi: 10.1177/0163278711433065. Epub 2012 Feb 7.

PMID:
22315505
49.

Effectiveness of public health quality improvement training approaches: application, application, application.

Davis MV, Vincus A, Eggers M, Mahanna E, Riley W, Joly B, Fisher JS, Bowling MJ.

J Public Health Manag Pract. 2012 Jan-Feb;18(1):E1-7. doi: 10.1097/PHH.0b013e3182249505.

PMID:
22139319
50.

Quality improvement learning collaboratives in public health: findings from a multisite case study.

Joly BM, Booth M, Shaler G, Conway A.

J Public Health Manag Pract. 2012 Jan-Feb;18(1):87-94. doi: 10.1097/PHH.0b013e3182367db1.

PMID:
22139316

Supplemental Content

Support Center